Dr. Faisal Azam

Consultant Medical Oncologist.
King Fahd Specialist Hospital, Dammam, KSA

09 : 55 – 10 : 05

24 June | 2023 Day 2

Multicenter randomized phase III trial of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as perioperative chemotherapy for muscle-invasive bladder cancer (MIBC): Overall survival (OS) data at 5 years in the GETUG/AFU V05 VESPER trial